First Year After Launch: Achieving Your Uptake Goals
Monday, June 22, 1:00PM ET
To accomplish these goals, your market access team must continuously monitor uptake, utilization and demand—and shift your strategy as needed to correct course. In this webinar, our market access experts will discuss how the right tools and processes can help your team influence payer policies, increase prescriber confidence, and simplify the path to treatment.
Register to Access the Webinar
This webinar explores how pharmaceutical companies are moving market access planning earlier into phases 1–3 to improve launch readiness, optimize value strategy, and reduce commercial risk.
This webinar explores how pharmaceutical companies can reduce market access risk during the critical pre-launch period leading up to FDA approval.
The Commercialization Playbook
This four-part webinar series provides practical strategies for launch readiness, uptake and lifecycle success to help your team navigate commercialization from Phase II to brand maturity.
Previous Webinar Sessions
In this BioPharma Dive webinar, Hannah Baxter, partner at The Dedham Group, and Steve Callahan, senior director of Advisory & Insights, MMIT, share insights from our 2025 State of Patient Access survey.
In this webinar, we’ll explain how MMIT, with NorstellaLinQ, developed a robust, unified dataset to provide comprehensive insights into a rare disease population.
In this webinar, learn how best practices for targeting and engaging physicians both in-person and via non-personal promotion techniques.
In the immediate post-launch timeframe, pharma companies can use market access research to improve coverage and utilization. In this webinar, our experts explain the benefits of everything from post-label indication research to competitor analyses and payer/IDN perception tracking.
In this webinar, MMIT’s Steve Callahan and AssistRx’s Brok Vandersteen discuss the payer, regulatory and market updates that will impact patient services’ financial assistance programs in 2025.
In this webinar, learn what kinds of market access research pharma companies should complete in the six to twelve months before launch to strengthen their performance.